MicroRNA-154: A Novel Candidate for Diagnosis and Therapy of Human Cancers

References

• Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34. doi:10.3322/caac.2155130620402
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg Robert A. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi:10.1016/j.cell.2011.02.01321376230
   PubMed Web of Science ®Google Scholar
• Hesari Z, Nourbakhsh M, Hosseinkhani S, et al. Down-regulation of NAMPT expression by mir-206 reduces cell survival of breast cancer cells. Gene. 2018;673:149–158. doi:10.1016/j.gene.2018.06.02129886033
   PubMed Web of Science ®Google Scholar
• Yarahmadi S, Abdolvahabi Z, Hesari Z, et al. Inhibition of sirtuin 1 deacetylase by miR-211-5p provides a mechanism for the induction of cell death in breast cancer cells. Gene. 2019;711:143939. doi:10.1016/j.gene.2019.06.02931220581
   PubMed Web of Science ®Google Scholar
• Cloonan N, Wani S, Xu Q, et al. MicroRNAs and their isomiRs function cooperatively to target common biological pathways. Genome Biol. 2011;12(12):R126. doi:10.1186/gb-2011-12-12-r12622208850
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297. doi:10.1016/S0092-8674(04)00045-514744438
   PubMed Web of Science ®Google Scholar
• Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T. Identification of novel genes coding for small expressed RNAs. Science. 2001;294(5543):853–858. doi:10.1126/science.106492111679670
   PubMed Web of Science ®Google Scholar
• Macfarlane LA, Murphy PR. MicroRNA: biogenesis, function and role in cancer. Curr Genomics. 2010;11(7):537–561. doi:10.2174/13892021079317589521532838
   PubMed Web of Science ®Google Scholar
• Cho Y, Baldán Á. Quest for new biomarkers in atherosclerosis. Missouri Med. 2013;110(4):325.24003651
   PubMedGoogle Scholar
• Catalanotto C, Cogoni C, Zardo G. MicroRNA in control of gene expression: an overview of nuclear functions. Int J Mol Sci. 2016;17(10):1712. doi:10.3390/ijms17101712
   PubMed Web of Science ®Google Scholar
• Lindow M, Kauppinen S. Discovering the first microRNA-targeted drug. J Cell Biol. 2012;199(3):407–412. doi:10.1083/jcb.20120808223109665
   PubMed Web of Science ®Google Scholar
• Van der Ree M, Van Der Meer A, Van Nuenen A, et al. Miravirsen dosing in chronic hepatitis C patients results in decreased micro RNA‐122 levels without affecting other micro RNA s in plasma. Aliment Pharmacol Ther. 2016;43(1):102–113. doi:10.1111/apt.1343226503793
   PubMed Web of Science ®Google Scholar
• Milosevic J, Pandit K, Magister M, et al. The role and regulation of miR-154 microRNA family in lung fibrosis Am J Respir Crit Care Med. 2010;181:A2019.
   Google Scholar
• Milosevic J, Pandit K, Magister M, et al. Profibrotic role of miR-154 in pulmonary fibrosis. Am J Respir Cell Mol Biol. 2012;47(6):879–887. doi:10.1165/rcmb.2011-0377OC23043088
   PubMed Web of Science ®Google Scholar
• Chen M, Yang Y, Zhang W, et al. Long noncoding RNA SNHG5 knockdown alleviates neuropathic pain by targeting the miR-154-5p/CXCL13 axis. Neurochem Res. 2020. doi:10.1007/s11064-020-03021-2
   Web of Science ®Google Scholar
• Ren H, Ma X, Shao Y, Han J, Yang M, Wang Q. Correlation between serum miR-154-5p and osteocalcin in males and postmenopausal females of type 2 diabetes with different urinary albumin creatinine ratios. Front Endocrinol. 2019;10:542. doi:10.3389/fendo.2019.00542
   PubMed Web of Science ®Google Scholar
• Gao Q, Ju Z, Zhang Y, et al. Association of TNP2 gene polymorphisms of the bta-miR-154 target site with the semen quality traits of Chinese Holstein bulls. PLoS One. 2014;9(1).
   Web of Science ®Google Scholar
• Pateisky P, Pils D, Szabo L, et al. hsa-miRNA-154-5p expression in plasma of endometriosis patients is a potential diagnostic marker for the disease. Reprod Biomed Online. 2018;37(4):449–466. doi:10.1016/j.rbmo.2018.05.00729857988
   PubMed Web of Science ®Google Scholar
• Dong P, Liu W, Wang Z. MiR-154 promotes myocardial fibrosis through β-catenin signaling pathway. Eur Rev Med Pharmacol Sci. 2018;22(7):2052–2060. doi:10.26355/eurrev_201804_1473529687862
   PubMed Web of Science ®Google Scholar
• Ren H, Wu C, Shao Y, Liu S, Zhou Y, Wang Q. Correlation between serum miR-154-5p and urinary albumin excretion rates in patients with type 2 diabetes mellitus: a cross-sectional cohort study. Front Med. 2020;1–9.31823287
   PubMed Web of Science ®Google Scholar
• Wong T-S, Liu X-B, Wong BY-H, Ng RW-M, Yuen AP-W, Wei WI. Mature miR-184 as potential oncogenic microRNA of squamous cell carcinoma of tongue. Clin Cancer Res. 2008;14(9):2588–2592. doi:10.1158/1078-0432.CCR-07-066618451220
   PubMed Web of Science ®Google Scholar
• Qiao W, Cao N, Yang L. MicroRNA-154 inhibits the growth and metastasis of gastric cancer cells by directly targeting MTDH. Oncol Lett. 2017;14(3):3268–3274. doi:10.3892/ol.2017.655828927076
   PubMed Web of Science ®Google Scholar
• Song J, Guan Z, Li M, et al. MicroRNA-154 inhibits the growth and invasion of gastric cancer cells by targeting DIXDC1/WNT signaling. Oncol Res. 2018;26(6):847–856. doi:10.3727/096504017X1501633725463228800791
   PubMed Web of Science ®Google Scholar
• Komiya Y, Habas R. Wnt signal transduction pathways. Organogenesis. 2008;4(2):68–75. doi:10.4161/org.4.2.585119279717
   PubMedGoogle Scholar
• Chung JY, Park YR, Choi SH, Seo SY, Lee ST, Kim SW. miR-124 and miR-154 inhibit colorectal cancer cell proliferation, migration, and invasion by suppressing TRAF6. Paper presented at: Journal of Gastroenterology and Hepatology; 2018; NJ USA.
   Google Scholar
• Xin C, Zhang H, Liu Z. miR-154 suppresses colorectal cancer cell growth and motility by targeting TLR2. Mol Cell Biochem. 2014;387(1–2):271–277. doi:10.1007/s11010-013-1892-324242044
   PubMed Web of Science ®Google Scholar
• D’Angelo E, Fassan M, Maretto I, et al. Serum miR-125b is a non-invasive predictive biomarker of the pre-operative chemoradiotherapy responsiveness in patients with rectal adenocarcinoma. Oncotarget. 2016;7(19):28647–28657. doi:10.18632/oncotarget.872527081702
   PubMedGoogle Scholar
• Xu M, Chen X, Lin K, et al. The long noncoding RNA SNHG1 regulates colorectal cancer cell growth through interactions with EZH2 and miR-154-5p. Mol Cancer. 2018;17(1):1–16. doi:10.1186/s12943-018-0894-x29304823
   PubMedGoogle Scholar
• Naghavi M, Abajobir AA, Abbafati C, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1151–1210. doi:10.1016/S0140-6736(17)32152-928919116
   PubMed Web of Science ®Google Scholar
• Niu J-T, Zhang L-J, Huang Y-W, Li C, Jiang N, Niu Y-J. MiR-154 inhibits the growth of laryngeal squamous cell carcinoma by targeting GALNT7. Biochem Cell Biol. 2018;96(6):752–760. doi:10.1139/bcb-2018-004729874469
   PubMedGoogle Scholar
• Huang J, Wu J, Li Y, et al. Deregulation of serum microRNA expression is associated with cigarette smoking and lung cancer. Biomed Res Int. 2014;2014:1–13. doi:10.1155/2014/364316
   Web of Science ®Google Scholar
• Cazzoli R, Buttitta F, Di Nicola M, et al. microRNAs derived from circulating exosomes as noninvasive biomarkers for screening and diagnosing lung cancer. J Thorac Oncol. 2013;8(9):1156–1162. doi:10.1097/JTO.0b013e318299ac3223945385
   PubMed Web of Science ®Google Scholar
• Lin X, Yang Z, Zhang P, Shao G. miR-154 suppresses non-small cell lung cancer growth in vitro and in vivo. Oncol Rep. 2015;33(6):3053–3060. doi:10.3892/or.2015.389525846246
   PubMed Web of Science ®Google Scholar
• Lin X, Yang Z, Zhang P, Liu Y, Shao G. miR-154 inhibits migration and invasion of human non-small cell lung cancer by targeting ZEB2. Oncol Lett. 2016;12(1):301–306. doi:10.3892/ol.2016.457727347142
   PubMed Web of Science ®Google Scholar
• Xue YJ, Fu YJ, Wang JH. The inhibitory effect of MIR-154-3p on metastasis of non-small cell lung cancer cell lines. Tumor. 2015;35:498–507.
   Google Scholar
• Lingling J, Xiangao J, Guiqing H, Jichan S, Feifei S, Haiyan Z. SNHG20 knockdown suppresses proliferation, migration and invasion, and promotes apoptosis in non-small cell lung cancer through acting as a miR-154 sponge. Biomed Pharmacother. 2019;112:108648. doi:10.1016/j.biopha.2019.10864830780105
   PubMed Web of Science ®Google Scholar
• Zheng W, Feng Q, Liu J, et al. Inhibition of 6-phosphogluconate dehydrogenase reverses cisplatin resistance in ovarian and lung cancer. Front Pharmacol. 2017;8:421. doi:10.3389/fphar.2017.0042128713273
   PubMed Web of Science ®Google Scholar
• Lin J, Spitz MR, Dinney CP, Etzel CJ, Grossman HB, Wu X. Bladder cancer risk as modified by family history and smoking. Cancer. 2006;107(4):705–711. doi:10.1002/cncr.2207116845665
   PubMed Web of Science ®Google Scholar
• Zhang J, Mao S, Wang L, et al. MicroRNA-154 functions as a tumor suppressor in bladder cancer by directly targeting ATG7. Oncol Rep. 2019;41(2):819–828. doi:10.3892/or.2018.687930483807
   PubMed Web of Science ®Google Scholar
• Zhao X, Ji Z, Xie Y, Liu G, Li H. MicroRNA-154 as a prognostic factor in bladder cancer inhibits cellular malignancy by targeting RSF1 and RUNX2. Oncol Rep. 2017;38(5):2727–2734. doi:10.3892/or.2017.599229048677
   PubMed Web of Science ®Google Scholar
• Wu C, Xu H, Zhang M, et al. Downregulation of miR‐154 in cervical cancer and its clinicopathological and prognostic significance. Int J Clin Exp Med. 2016;9(10):19791–19796.
   Web of Science ®Google Scholar
• Lin C, Li Z, Chen P, et al. Oncogene miR-154-5p regulates cellular function and acts as a molecular marker with poor prognosis in renal cell carcinoma. Life Sci. 2018;209:481–489. doi:10.1016/j.lfs.2018.08.04430138594
   PubMed Web of Science ®Google Scholar
• Rawla P. Epidemiology of prostate cancer. World J Oncol. 2019;10(2):63–89. doi:10.14740/wjon119131068988
   PubMedGoogle Scholar
• Dambal S, Giangreco AA, Acosta AM, et al. microRNAs and DICER1 are regulated by 1, 25-dihydroxyvitamin D in prostate stroma. J Steroid Biochem Mol Biol. 2017;167:192–202. doi:10.1016/j.jsbmb.2017.01.00428089917
   PubMed Web of Science ®Google Scholar
• Formosa A, Markert E, Lena A, et al. MicroRNAs, miR-154, miR-299-5p, miR-376a, miR-376c, miR-377, miR-381, miR-487b, miR-485-3p, miR-495 and miR-654-3p, mapped to the 14q32. 31 locus, regulate proliferation, apoptosis, migration and invasion in metastatic prostate cancer cells. Oncogene. 2014;33(44):5173–5182. doi:10.1038/onc.2013.45124166498
   PubMed Web of Science ®Google Scholar
• Zhu C, Li J, Cheng G, et al. miR-154 inhibits EMT by targeting HMGA2 in prostate cancer cells. Mol Cell Biochem. 2013;379(2):69–75. doi:10.1007/s11010-013-1628-423591597
   PubMed Web of Science ®Google Scholar
• Zhu C, Shao P, Bao M, et al. miR-154 inhibits prostate cancer cell proliferation by targeting CCND2 Urologic Oncology: Seminars and Original Investigations. 2014;32(1):31e9–16.
   Web of Science ®Google Scholar
• Zheng Y, Zhu C, Ma L, et al. miRNA-154-5p inhibits proliferation, migration and invasion by targeting E2F5 in prostate cancer cell lines. Urol Int. 2017;98(1):102–110. doi:10.1159/00044525227074041
   PubMed Web of Science ®Google Scholar
• Patel AP, Fisher JL, Nichols E, et al. Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol. 2019;18(4):376–393. doi:10.1016/S1474-4422(18)30468-X30797715
   PubMed Web of Science ®Google Scholar
• Wang L, Wu L, Wu J. Downregulation of miR-154 in human glioma and its clinicopathological and prognostic significance. J Int Med Res. 2016;44(5):994–1001. doi:10.1177/030006051664948727417886
   PubMed Web of Science ®Google Scholar
• Wang X, Sun S, Tong X, et al. MiRNA-154-5p inhibits cell proliferation and metastasis by targeting PIWIL1 in glioblastoma. Brain Res. 2017;1676:69–76. doi:10.1016/j.brainres.2017.08.01428842123
   PubMed Web of Science ®Google Scholar
• Zhou H, Zhang Y, Lai Y, Xu C, Cheng Y. Circ_101064 regulates the proliferation, invasion and migration of glioma cells through miR-154–5p/PIWIL1 axis. Biochem Biophys Res Commun. 2020. doi:10.1016/j.abb.2020.108366
   Google Scholar
• Yang L, Yan Z, Wang Y, Ma W, Li C. Down‐expression of miR‐154 suppresses tumourigenesis in CD133+ glioblastoma stem cells. Cell Biochem Funct. 2016;34(6):404–413. doi:10.1002/cbf.320127338789
   PubMed Web of Science ®Google Scholar
• DeSantis CE, Ma J, Gaudet MM, et al. Breast cancer statistics, 2019. CA Cancer J Clin. 2019;69(6):438–451. doi:10.3322/caac.2158331577379
   PubMed Web of Science ®Google Scholar
• Lowery A, Miller N, McNeill R, Kerin M. MicroRNA expression in primary breast tumors. Poster presented at: 30 th Annual San Antonio Breast Cancer Symposium; 2007; Texas-USA.
   Google Scholar
• Miranda P, Vimalraj S, Selvamurugan N. A feedback expression of microRNA-590 and activating transcription factor-3 in human breast cancer cells. Int J Biol Macromol. 2015;72:145–150. doi:10.1016/j.ijbiomac.2014.07.05125150595
   PubMed Web of Science ®Google Scholar
• Li S, Meng H, Zhou F, et al. MicroRNA-132 is frequently down-regulated in ductal carcinoma in situ (DCIS) of breast and acts as a tumor suppressor by inhibiting cell proliferation. Pathol Res Pract. 2013;209(3):179–183. doi:10.1016/j.prp.2012.12.00223399321
   PubMed Web of Science ®Google Scholar
• Lowery A, Miller N, Kerin M. Expression of the putative breast cancer gene BASE; relationship with microRNA-154* and estrogen receptor status. Poster presented at: 30 th Annual San Antonio Breast Cancer Symposium; 2007; Texas-USA.
   Google Scholar
• Xu H, Fei D, Zong S, Fan Z. MicroRNA-154 inhibits growth and invasion of breast cancer cells through targeting E2F5. Am J Transl Res. 2016;8(6):2620.27398145
   PubMed Web of Science ®Google Scholar
• Qin C, Zhao Y, Gong C, Yang Z. MicroRNA-154/ADAM9 axis inhibits the proliferation, migration and invasion of breast cancer cells. Oncol Lett. 2017;14(6):6969–6975. doi:10.3892/ol.2017.702129163713
   PubMed Web of Science ®Google Scholar
• Pour ZB, Nourbakhsh M, Mousavizadeh K, et al. Suppression of nicotinamide phosphoribosyltransferase expression by miR-154 reduces the viability of breast cancer cells and increases their susceptibility to doxorubicin. BMC Cancer. 2019;19(1):1–13. doi:10.1186/s12885-018-5219-330606139
   PubMed Web of Science ®Google Scholar
• Chi J-R, Yu Z-H, Liu B-W, et al. SNHG5 promotes breast cancer proliferation by sponging the miR-154-5p/PCNA axis. Mol Ther Nucleic Acids. 2019;17:138–149. doi:10.1016/j.omtn.2019.05.01331255976
   PubMedGoogle Scholar
• Goodarzi E, Ghorat F, Jarrahi A, Adineh H, Sohrabivafa M, Khazaei Z. Global incidence and mortality of liver cancers and its relationship with the human development index (HDI): an ecology study in 2018. World J Cancer Res. 2019;6:12.
   Google Scholar
• Wang W, Peng B, Wang D, et al. Human tumor microRNA signatures derived from large‐scale oligonucleotide microarray datasets. Int J Cancer. 2011;129(7):1624–1634. doi:10.1002/ijc.2581821128228
   PubMed Web of Science ®Google Scholar
• Pang X, Huang K, Zhang Q, Zhang Y, Niu J. miR-154 targeting ZEB2 in hepatocellular carcinoma functions as a potential tumor suppressor. Oncol Rep. 2015;34(6):3272–3279. doi:10.3892/or.2015.432126503460
   PubMed Web of Science ®Google Scholar
• Feng J, Yang G, Liu Y, et al. LncRNA PCNAP1 modulates hepatitis B virus replication and enhances tumor growth of liver cancer. Theranostics. 2019;9(18):5227. doi:10.7150/thno.3427331410212
   PubMed Web of Science ®Google Scholar
• Rawla P, Sunkara T, Gaduputi V. Epidemiology of pancreatic cancer: global trends, etiology and risk factors. World J Oncol. 2019;10(1):10. doi:10.14740/wjon116630834048
   PubMedGoogle Scholar
• Wei DM, Jiang MT, Lin P, et al. Potential ceRNA networks involved in autophagy suppression of pancreatic cancer caused by chloroquine diphosphate: a study based on differentially‑expressed circRNAs, lncRNAs, miRNAs and mRNAs. Int J Oncol. 2019;54(2):600–626. doi:10.3892/ijo.2018.466030570107
   PubMed Web of Science ®Google Scholar
• Mian C, Pennelli G, Fassan M, et al. MicroRNA profiles in familial and sporadic medullary thyroid carcinoma: preliminary relationships with RET status and outcome. Thyroid. 2012;22(9):890–896. doi:10.1089/thy.2012.004522747440
   PubMed Web of Science ®Google Scholar
• X-d F, Luo Y, Wang J, An N. miR-154-3p and miR-487-3p synergistically modulate RHOA signaling in the carcinogenesis of thyroid cancer. Biosci Rep. 2020;40(1). doi:10.1042/BSR20193470
   Google Scholar
• Mirabello L, Troisi RJ, Savage SA. Osteosarcoma incidence and survival rates from 1973 to 2004: data from the surveillance, epidemiology, and end results program. Cancer. 2009;115(7):1531–1543. doi:10.1002/cncr.2412119197972
   PubMed Web of Science ®Google Scholar
• Geller DS, Gorlick R. Osteosarcoma: a review of diagnosis, management, and treatment strategies. Clin Adv Hematol Oncol. 2010;8(10):705–718.21317869
   PubMedGoogle Scholar
• Tian Q, Gu Y, Wang F, et al. Upregulation of miRNA-154-5p prevents the tumorigenesis of osteosarcoma. Biomed Pharmacother. 2020;124:109884. doi:10.1016/j.biopha.2020.10988432000044
   PubMed Web of Science ®Google Scholar
• Zhou H, Zhang M, Yuan H, Zheng W, Meng C, Zhao D. MicroRNA-154 functions as a tumor suppressor in osteosarcoma by targeting Wnt5a. Oncol Rep. 2016;35(3):1851–1858. doi:10.3892/or.2015.449526708300
   PubMed Web of Science ®Google Scholar
• Matthews N, Li W, Qureshi A, Weinstock M, Cho E. Epidemiology of melanoma In: Ward W, Farma J, editors. Cutaneous Melanoma: Etiology and Therapy [Internet]. Brisbane (AU): Codon Publications; 2017.
   Google Scholar
• Wang J, Fang Y, Liu Y, et al. MiR-154 inhibits cells proliferation and metastasis in melanoma by targeting AURKA and serves as a novel prognostic indicator. Eur Rev Med Pharmacol Sci. 2019;23(10):4275–4284. doi:10.26355/eurrev_201905_1793231173299
   PubMed Web of Science ®Google Scholar
• Chen H-Q, Gao D. Inhibitory effect of microRNA-154 targeting WHSC1 on cell proliferation of human skin squamous cell carcinoma through mediating the P53 signaling pathway. Int J Biochem Cell Biol. 2018;100:22–29. doi:10.1016/j.biocel.2018.04.02129727714
   PubMed Web of Science ®Google Scholar
• Gururajan M, Josson S, Chu GC-Y, et al. miR-154* and miR-379 in the DLK1-DIO3 microRNA mega-cluster regulate epithelial to mesenchymal transition and bone metastasis of prostate cancer. Clin Cancer Res. 2014;20(24):6559–6569.25324143
   PubMed Web of Science ®Google Scholar
• Dixon-McIver A, East P, Mein CA, et al. Distinctive patterns of microRNA expression associated with karyotype in acute myeloid leukaemia. PLoS One. 2008;3(5):e2141. doi:10.1371/journal.pone.000214118478077
   PubMed Web of Science ®Google Scholar
• Mei J, Xu R, Hao L, Zhang Y. MicroRNA-613: a novel tumor suppressor in human cancers. Biomed Pharmacother. 2020;123:109799. doi:10.1016/j.biopha.2019.10979931877552
   PubMed Web of Science ®Google Scholar
• Jabbari N, Zarei L, Esmaeili Govarchin Galeh H, Mansori Motlagh B. Assessment of synergistic effect of combining hyperthermia with irradiation and calcium carbonate nanoparticles on proliferation of human breast adenocarcinoma cell line (MCF-7 cells). Artif Cells Nanomed Biotechnol. 2018;46(sup2):364–372. doi:10.1080/21691401.2018.145753729616844
   PubMed Web of Science ®Google Scholar